Condition: Liver Cancer · Sponsor: JIANGSU SHENMING Medical Technology CO., Ltd
This is a prospective, multicenter, randomized, parallel-controlled, non-inferiority clinical trial that will be conducted at multiple clinical trial institutions in China. The trial is divided into two phases: the lead-in phase and the main study phase, with a total of 216 subjects planned to be enrolled. In the main study phase, subjects will be randomly assigned in a 1:1 ratio to either the test group or the control group. The randomly assigned subjects will receive TACE treatment. The test group will receive embolization therapy with anthracycline chemotherapy drugs, iodinated oil, and tumor temperature-sensitive embolic agents (test group), while the control group will receive embolization therapy with anthracycline chemotherapy drugs, iodinated oil, and gelatin sponge particles (control group).
This description comes directly from the study's public registry record.
Huamin Wang · +86 15116996413 · huaminwang@grandpharma.cn
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Affiliated Cancer Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| The Affiliated Cancer Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Recruiting |
| The Fourth Hospital of Hebei Medical University (Hebei Provincial Cancer Hospital) | Shijiazhuang, Hebei, China | Recruiting |
| Anyang Tumor Hospital | Anyang, Henan, China | Recruiting |
| The First Affiliated Hospital of Henan University of Science & Technology | Luoyang, Henan, China | Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Recruiting |
| Yichang Central People's Hospital | Yichang, Hubei, China | Recruiting |
| First Affiliated Hospital of Gannan Medical University | Ganzhou, Jiangxi, China | Recruiting |
| The Second Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Recruiting |
| Jilin Guowen Hospital | Gongzhuling, Jilin, China | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356531